Henry Daniell is an accomplished scientist and professor who currently serves as the Director and Professor of Biochemistry and Pathology at the University of Pennsylvania. With over three decades of experience in academia, Daniell has made significant contributions to the fields of molecular biology and plant genetic engineering. He is also the founder of the Daniell Lab, which focuses on developing novel technologies and biopharmaceuticals that address unmet medical needs. Some of his most notable projects include the use of plant-based vaccines for diabetes and tuberculosis, and the development of oral insulin for the treatment of diabetes. Daniell has received numerous awards and accolades, including the Innovator of the Year award from the Philadelphia Business Journal, and has been elected as a fellow of several prestigious scientific societies.